Braxia Scientific Corp (BRAXF)
Braxia Scientific Corp. is a Toronto-based healthcare company focused on medical research and mental health treatment services. Through its clinics, the company provides ketamine-based treatments for patients with depression and related disorders, and it also operates multidisciplinary clinics that treat a range of mental health conditions. Alongside its clinical activities, Braxia Scientific pursues research aimed at developing and commercializing new drugs and delivery methods. Its broader work includes the development and acquisition of ketamine and psilocybin derivatives, as well as other psychedelic-related products, through its intellectual property platform. The company’s common stock trades on OTC Markets.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BRAX.F
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
1.007 M
|
—
|
—
|
—
|
—
|
—
|
—
|
